Charles Schwab’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,401
| Closed | -$130K | – | 3568 |
|
|
2023
Q4 | $130K | Buy |
+11,401
| New | +$130K | ﹤0.01% | 3327 |
|
|
2022
Q3 | – | Sell |
-1,023
| Closed | -$20K | – | 3562 |
|
|
2022
Q2 | $20K | Sell |
1,023
-4,337
| -81% | -$84.8K | ﹤0.01% | 3519 |
|
|
2022
Q1 | $267K | Buy |
5,360
+372
| +7% | +$18.5K | ﹤0.01% | 3247 |
|
|
2021
Q4 | $377K | Hold |
4,988
| – | – | ﹤0.01% | 3235 |
|
|
2021
Q3 | $395K | Sell |
4,988
-12,322
| -71% | -$976K | ﹤0.01% | 3206 |
|
|
2021
Q2 | $2.4M | Buy |
17,310
+1,672
| +11% | +$232K | ﹤0.01% | 2655 |
|
|
2021
Q1 | $3.27M | Buy |
15,638
+4,042
| +35% | +$846K | ﹤0.01% | 2496 |
|
|
2020
Q4 | $1.93M | Buy |
11,596
+694
| +6% | +$115K | ﹤0.01% | 2596 |
|
|
2020
Q3 | $1.85M | Buy |
10,902
+3,776
| +53% | +$642K | ﹤0.01% | 2512 |
|
|
2020
Q2 | $1.18M | Buy |
7,126
+2,552
| +56% | +$424K | ﹤0.01% | 2576 |
|
|
2020
Q1 | $530K | Buy |
4,574
+58
| +1% | +$6.72K | ﹤0.01% | 2691 |
|
|
2019
Q4 | $668K | Buy |
4,516
+44
| +1% | +$6.51K | ﹤0.01% | 2720 |
|
|
2019
Q3 | $611K | Buy |
4,472
+732
| +20% | +$100K | ﹤0.01% | 2724 |
|
|
2019
Q2 | $487K | Buy |
3,740
+723
| +24% | +$94.1K | ﹤0.01% | 2823 |
|
|
2019
Q1 | $286K | Buy |
+3,017
| New | +$286K | ﹤0.01% | 2950 |
|